Pratt Foundation donates $1M toward COVID-19 treatment

The Australia-based foundation’s donation will be used toward a trial of existing drugs that could be used to treat COVID-19.

Pratt Recycling equipment Machinex in Atlanta
Vertically integrated Pratt Industries’ newest material recovery facility (MRF) was built four years ago in Conyers, Georgia. It handles residential recyclables from the city of Atlanta, DeKalb County and the surrounding area.
Pratt Industries

The Pratt Foundation, the philanthropic arm of Australia-based packaging company Visy Industries, has announced that it is donating $1 million to fund the trial of two drugs that may help COVID-19 patients. The donation is led by Anthony Pratt, chairman of Visy Industries and Pratt Industries, which offers packaging and recycling services across the world.

The $1 million donation went to the Peter Doherty Institute for Infection and Immunity at the University of Melbourne, which will be used in a trial of existing HIV and arthritis drugs that could be used to treat COVID-19. According to a news release from Visy Industries, the trial will involve 2,440 people over 60 days in 60 hospitals across Australia and New Zealand. 

Overall, the trial costs $6.7 million, U.K.-based newspaper The Daily Mail states in a news release. The Daily Mail also reports that Pratt issued a “call to arms” to the wealthiest individuals in Australia to fight against COVID-19 by offering help. Pratt has an estimated fortune of $16.95 billion. There are currently 4,860 confirmed cases of COVID-19 in Australia.